Neith

Neith EBITDA CAGR 5Y

EBITDA CAGR (5 Year) of Neith (6236.TWO) as of Nov 5, 2026.

EBITDA CAGR 5Y

-

Last updated:

EBITDA CAGR (5 Year) of Neith is 2026 - . EBITDA CAGR (5 Year) of Neith was 2025 - . It decreases by % lower compared to the previous year.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Neith Stock analysis

What does Neith do? Neith Corp generates revenue through two distinct business segments: biomedical and semiconductor. The biomedical segment focuses on the manufacture and sales of rock baths, peripheral products, and negative ion products, alongside the provision of preventive medical services including genetic testing and consulting. Additionally, the firm engages in the rental of medical instruments to support its healthcare offerings. The semiconductor segment is primarily dedicated to the development of integrated circuit products, such as microcontrollers and their peripheral products. These products are mainly targeted at domestic sales. Neith is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Neith stock

On Eulerpool you can find the complete historical development of EBITDA CAGR (5 Year) Neith since 2006 – with annual values, charts, and detailed analysis.

The 5-year EBITDA CAGR shows the compound annual growth rate of EBITDA over five years.

To evaluate EBITDA CAGR (5 Year)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EBITDA CAGR (5 Year).

EBITDA CAGR (5 Year)'s is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBITDA CAGR (5 Year)'s Neith historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Growth — Neith

All Key Metrics — Neith